PRESCRIBING IN THE ELDERLY. CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas

Similar documents
Medication Reviews within Care Homes. Catherine Armstrong

Polypharmacy: Guidance for Prescribing in Frail Adults

Geriatric Pharmacology

Deconstructing Polypharmacy. Alan B. Douglass, M.D. Director

STOPP START Toolkit Supporting Medication Review in the Older Person

1/21/2016 UPDATE ON THE AMERICAN GERIATRICS SOCIETY 2015 BEERS CRITERIA DISCLOSURE OBJECTIVES AGING GOALS BEERS CRITERIA

COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK

Prescribing in the Elderly. Dr Alison Macrae and Dr Debbie Vest GPST2 Drs in Psychiatry

Prescribing Dilemmas. Sue Mulvenna Head of Pharmacy and CD Accountable Officer South Region SW 19 th May

Pharmaceutical Care for Geriatrics

Reviewing Medicines in at risk patients care homes

Taking the harm out of Polypharmacy Step by step. Karen Reid and Claire Stein Lead Integrated Care Pharmacist NHS Lothian

POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE

Maximizing Medication Safety UNIVERSITY OF HAWAII AUGUST 31, 2016

Geri-PARDY! (2015 Beers Criteria) Pharmacology Edition

Chitra Fernando, MD March 18, 2008

Rational prescribing in the older adult. Assoc Prof Craig Whitehead

Define frailty Recognise the consequences of frailty Know why CGA important and what are the main components of a CGA that can be done in an initial

Pharmacology in the Elderly

Polypharmacy. A CPPE distance learning programme

DRUG THERAPY CHOICES FOR THE DEMENTED PATIENT Past, Present and Future

STOPP and START criteria October 2011

Katee Kindler, PharmD, BCACP

Safe Prescribing in Dementia

Optimising prescribing in primary care in the face of multimorbidity and polypharmacy

ESSENTIAL CARE AFTER AN IN-PATIENT FALL

Primary Care management of Overactive Bladder (OAB)

Deprescribing with Confidence Dr Sanjay Suman MD FRCP

Medications Contributing to Falls. Kate Niemann, PharmD BCGP AuBurn Pharmacy

Application for Endorsement of CQI (Clinical Audit) Activities for MOPS Credits Allocation

DEPRESCRIBING IN THE ELDERLY

Tackling inappropriate polypharmacy in NHS Scotland

Intelligent Polypharmacy. Professor Colin P Bradley Department of General Practice University College Cork

BEERs For the Elderly

Prescribing Drugs to the Elderly

START, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy

KEY MESSAGES. It is often under-recognised and 30-50% of MDD cases in primary care and medical settings are not detected.

Medication Use in Older Adults

Introductory Clinical Pharmacology Chapter 32 Antiparkinsonism Drugs

From MCI to Dementia DR YU- MIN LIN GERIATRICIAN AUG 2018

Preventing Falls in Older Adults A Matter of Safety

WEBINAR SERIES: AGING IN INDIVIDUALS WITH INTELLECTUAL AND DEVELOPMENTAL DISABILITIES

How to prescribe The elderly. Andi Shirtcliffe Pharmacist

Guidelines MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD)

Black holes taped on floor Redirection Music and activities Yellow straps across the door Remind other residents to use call bell when she comes in

ESPEN Congress The Hague 2017

Supporting Last Days of Life Symptom Control Medication Guidance: Algorithm. Agitation & Anxiety

SECTION 9 : MANAGEMENT OF MOVEMENT DISORDERS AND EXTRAPYRAMIDAL SIDE EFFECTS

Pitfalls in Pharmacotherapy of Geriatrics

Prevention of Medication-Related Falls Through Appropriate Medication Use. Clay Sprouse, MEd., CPhT Piedmont Technical College

Using the ASCP-NCOA Falls Risk Reduction Toolkit Part 1: A Companion to CDC's STEADI Toolkit

Medication: A Double-Edged Sword for Older ID/DD Adults. Presenter: Ronald Lucchino, PhD

Polypharmacy: Guidance for Prescribing Figure 2: A Practical Guide to Stopping Medication in the Elderly

Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist

STOPP START Toolkit Supporting Medication Review

University of Hawaii Center on Aging

Geriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center

Nephrology. 3 rd Year Revision Session 06/05/17 Cathal Hannan

PRESCRIBING PRACTICE IN DELIRIUM. John Warburton Critical Care Pharmacist

The Deprescribing of Psychotropic Medication in Service Users (Patients) with Learning Disability

Summary of Delirium Clinical Practice Guideline Recommendations Post Operative

HA CONVENTION Effectiveness of Pharmacist-led Frail Elderly Medication Service in Acute Geriatric Ward

A Geriatrician s Perspective on Successful Aging. Ariel Green, MD, MPH Assistant Professor of Medicine

Falls most commonly seen in RACFs are due to tripping, slipping and stumbling (21.6%). Falling down stairs is relatively uncommon in

Appendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over)

Palliative Prescribing - Pain

A Primer on Safe Prescribing to the Elderly. Dr. John Puxty

BLCS 1-Clinical Overview. Dr. Chris Rauscher Clinical Lead Shared Care Polypharmacy Risk Reduction Initiative

Formulary and Clinical Guideline Document Pharmacy Department Medicines Management Services

Overuse in hospitals. Prof. N. Rodondi, Leiter Poliklinik & Chefarzt

< = > less is more. De-diagnosing De-prescribing Non-testing

Amal AL-Anazi, BSc.(Pharm) Medication Safety Officer In Eastern Region

Use caution in the elderly: review of safe and effective medication use in older patients

Psychotropic Medication Use in Dementia

Polypharmacy. Polypharmacy. Suboptimal Prescribing in Older Adults. Kenneth Schmader, MD Professor of Medicine-Geriatrics

NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES

ENSURING EXCELLENCE IN PRESCRIBING FOR OLDER ADULTS

Disclosures. Use caution in the elderly: review of safe and effective medication use in older patients. Institute of Medicine. Learning Objectives

Cognitive enhancers PINCH ME. Anticholinergic burden BPSD. Agitation, Aggression and antipsychotics

Nursing Process Focus: Patients Receiving Levodopa (Larodopa)

Screening tools for elderly patients in primary care

Primary Care Approach for Evaluating the Risk of Falls with Elderly Patients. Danielle Hansen, DO, MS (Med Ed), MHSA

Palliative care for heart failure patients. Susan Addie

Appropriate prescribing and deprescribing for older people getting it right. Alan Davis Northland District Health Board

Delirium and Dementia

Aging and Geriatric Assessment March 31, 2008 Sharon Leigh, Pharm D. BCPS Providence ElderPlace

Managing Polypharmacy: Thinking outside the box

Gateshead Pain Guidelines for Chronic Conditions

Medications and the I/DD Population

Nortriptyline vs amitriptyline in elderly

Care homes: Good practice guide to prescribing and medication reviews

Frailty: what s it all about?

Elavil (amitriptyline)

TOP 5 DRUGS.. TO AVOID IN THE ELDERLY

Prescribing and Pharmacokinetic Considerations in the Elderly

A Drug-related Problem Risk Assessment Tool (DRP-RAT) for use by home care practical nurses

Interface Prescribing Subgroup DRUGS FOR DEMENTIA: INFORMATION FOR PRIMARY CARE

Norpramin (desipramine)

There s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients

Transcription:

PRESCRIBING IN THE ELDERLY CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas

LEARNING OUTCOMES Medicines Optimisation The effects of aging on health and medicines. Polypharmacy Acute Kidney Injury (AKI) Blood pressure and Falls Anticholinergic Burden (ACB) Tools supporting medication reviews.

MEDICINES OPTIMISATION A person-centred approach to safe and effective medicines use, to ensure people obtain the best possible outcomes from their medicines. NICE 2015

4 GUIDING PRINCIPLES NICE 2015 1. Aim to understand the patient s experience. 2. Ensure evidence- based choice of medicines. 3. Ensure medicines use is as safe as possible. 4. Make medicines optimisation part of routine practice.

THE EFFECTS OF AGING ON HEALTH AND MEDICINES Physical changes to body affects handling of medicines. Person s vulnerability to ADRs. Ability to take medicines. Co-morbidities. Polypharmacy. Non- adherence

Common side effects in older people Medicine Opiates (6.0%), psychotropics, BDZ, cimetidine, Ach NSAIDs (29.6%), SSRIs, prednisolone (2.5%) Warfarin (10.5%) Digoxin (2.9%) BDZs Amitriptyline, oxybutynin, hyoscine Possible Side Effect Agitation, insomnia, confusion, dizziness and EPS Nausea, vomiting, diarrhoea, constipation and GI bleeds Bleeding, bruising Confusion, hallucinations, bradycardia with standard doses Increased and prolonged sedative effects, risk of falls Confusion, blurred vision, constipation, urinary retention, increased heart rate with TCAs

POLYPHARMACY How many medicines do you think an elderly person may take on average (including OTC)? a) b) c) d) 0-3 4-6 7-8 16-20

POLYPHARMACY How much more likely is a person taking 10 or more medicines is to be admitted to hospital? a) 10% b) 50% c) 100% d) 300%

POLYPHARMACY Which medicines are most likely to cause hospital admissions due to ADRs? a) Antiplatelets b) Diuretics c) NSAIDs d) Anti-coagulants 16% 16% 11% 8%

FALLS (medicines related) Multiple anti-hypertensives Postural hypotension Sedatives Opioids Cough /cold medicines Antipsychotics / Antidepressants

Anti-cholinergic Burden (ACB) Use with caution esp in frail, elderly patients. Combination increases risk of side-effects Confusion, falls, death. Examples of medicines with high ACB score Oxybutynin / Tolteridine Paroxetine (SSRIs) Amitriptyline (TCAs) Olanzapine (Antipsychotics) Cetirizine (Antihistamines) Loperamide Carbamazepine

ACUTE KIDNEY INJURY Rapid deterioration in a patient s renal function over hours or days, characterised by reduced urine output and /or increased serum creatinine.

The NO TEARS Tool Need and Indication Open questions Tests and monitoring Evidence and guidelines Adverse events Risk Reduction/Prevention Simplification and switches Lewis 2004

STOPP START Toolkit Screening Tool of Older People s potentially inappropriate Prescriptions Is there a specific reason why a STOPP medication should be continued? Screening Tool to Alert prescribers to Right Treatments Is there a specific reason why a START medication should be continued?

Case Study Mrs Jones is an 88 year old lady Current Medications: living at home, close to her Diazepam 2mg 1on daugther. Glicazide 80mg om She has NIDDM, osteoporosis, Metformin 500mg tds osteoarthritis and hypertension. Omeprazole 20mg om She suffers from urinary incontinence (diagnosed 4 months Naproxen 500mg bd ago) and uses pads. Oxybutynin 2.5mg bd Fractured her hip 12 months ago. Ramipril 5mg od She was recently bereaved and Alendronic acid 70mg 1 weekly prescribed diazepam to help her sleep. She has come for a medication review with her daughter, who mentions she has recently become confused and constipated. Observations: Good diabetic control BP: 105/60

References NICE. Medicines optimisation: the safe and effective use of medicines to ensure the best possible outcomes. (NG5). 2015. www.nice.org.uk/guidance/ng5 NS836 Kaufman G (2016) Medicines Optimisation: priorities and challenges. Nursing Standard. 30, 30, 53-59 Bohemian Rhapsody : https://www.youtube.com/watch?v=lp3pfjkozl8 King s Fund. Polypharmacy and medicines optimisation. London: King s Fund; 2013 Department of Health. National Service Framework for Older People. London: Department of Health; 2001. Acknowledgement: CPPE Toolkits Polypharmacy Jan 2016. Older People May 2015 Acute Kidney Injury Sept 2015